Skip to main content
. 2019 Apr 17;23:130. doi: 10.1186/s13054-019-2394-9

Table 1.

Participant demographics and outcomes

Variable Total participants (n = 1657) Analytical sample (n = 1338) Excluded sample (n = 319) Included vs excluded p value
Demographics
 Male, % (n) 54.7 (907) 56.2 (753) 48.3 (154) < 0.01
 Age in years, mean (SD) 60.0 (18.9) 58.9 (19.0) 64.8 (17.7) < 0.01
Main outcomes
 MV-free days, mean (SD) 10.1 (10.7) 9.6 (10.4) 12.2 (11.7) < 0.01
 ICU-free days, mean (SD) 7.3 (8.9) 6.7 (8.5) 9.9 (10.1) < 0.01
 Hospital-free days, mean (SD) 11.1 (16.6) 10.8 (16.4) 12.4 (17.5) <0.05
 90-day mortality, % (n)* 49.1 (810) 50.1 (669) 44.5 (141) 0.07
Clinical parameters
 APACHE II score, mean (SD) 24.0 (7.8) 24.1 (7.9) 23.6 (7.5) 0.22
 APACHE III score, mean (SD) 82.7 (28.1) 83.6 (28.3) 78.9 (26.9) < 0.01
 SOFA score, mean (SD) 9.5 (3.5) 9.7 (3.5) 8.8 (3.6) < 0.01
 Prevalence of ARDS, % (n)** 17.5 (289) 19.7 (262) 8.5 (27) < 0.01
Hospital admission type*** 0.56
 Medical, % (n) 72.3 (1196) 72.4 (968) 71.7 (228)
 Trauma, % (n) 10.7 (177) 11.6 (155) 6.9 (22)
 Surgical (scheduled), % (n) 3.5 (58) 3.1 (42) 5.0 (16)
 Surgical (unscheduled), % (n) 10.8 (178) 9.8 (131) 14.8 (47)
 Other, % (n) 2.8 (46) 3.1 (41) 1.6 (5)

*From the 1657 participants, there were 6 participants whose death by 90 days was not recorded. Percentages (%) are obtained from all the participants whose status was known by 90 days

**From the 1657 participants there were 8 participants whose ARDS diagnosis was not determined. Percentages are obtained based on all participants where a yes/no ARDS diagnosis was recorded.

***From the 1657 participants there were 2 participants whose admission type was not obtained. Percentages are obtained from all those participants whose admission was obtained